CD34-positive cells and their subpopulations characterized by flow cytometry analyses on the bone marrow of healthy allogenic donors
Keywords:
Hematopoietic stem cells, Immunophenotyping, Antigens, CD34, Hematopoiesis, Bone marrow transplantationAbstract
CONTEXT AND OBJECTIVE: Counting and separating hematopoietic stem cells from different sources has importance for research and clinical assays. Our aims here were to characterize and quantify hematopoietic cell populations in marrow donors and to evaluate CD34 expression and relate this to engraftment. DESIGN AND SETTING: Cross-sectional study on hematopoietic stem cell assays, using flow cytometry on donor bone marrow samples, for allogenic transplantation patients at two hospitals in São Paulo. METHODS: Immunophenotyping of marrow cells was performed in accordance with positive findings of CD34FITC, CD117PE, CD38PE, CD7FITC, CD33PE, CD10FITC, CD19PE, CD14FITC, CD13PE, CD11cPE, CD15FITIC, CD22PE, CD61FITC and CD56PE monoclonal antibodies in CD45PerCP+ cells, searching for differentiation and maturation regions. CD34+ sorting cells were analyzed for CD38 and CD117. Rh-123 retention was done before and after sorting. Antigen expression and CD34+ cells were correlated with engraftment. RESULTS: In region R1, 0.1% to 2.8% of cells were CD34+/CD45+ and 1.1%, CD34+/CD45-. The main coexpressions of CD45+ cells were CD38, CD22, CD19 and CD56 in R2 and CD33, CD11c, CD14, CD15 and CD61 in R3 and R4. After sorting, 2.2x106 CD34+ cells were equivalent to 4.9% of total cells. Coexpression of CD34+/CD38+ and CD34+/CD117+ occurred in 94.9% and 82% of events, respectively. There was a positive relationship between CD34+ cells and engraftment. More than 80% of marrow cells expressed high Rh-123. CD34+ cell sorting showed that cells in regions of more differentiated lineages retained Rh-123 more intensively than in primitive lineage regions. CONCLUSION: We advocate that true stem cells are CD34+/CD45-/CD38-/low-Rh-123 accumulations.
Downloads
References
Dexter TM, Spooncer E. Growth and differentiation in the hemapoietic system. Annu Rev Cell Biol. 1987;3:423-41.
Gratama JW, Sutherland DR, Keeney M. Flow cytometric enumeration and immunophenoty- ping of hematopoietic stem and progenitor cells. Semin Hematol. 2001;38(2):139-47.
Andrews RG, Singer JW, Bernstein ID. Monoclonal antibody 12-8 recognizes a 115-kd mo- lecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood. 1986;67(3):842-5.
Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol. 1984;133(1):157-65.
McGuckin CP, Pearce D, Forraz N, Tooze JA, Watt SM, Pettengell R. Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow. Eur J Haematol. 2003;71(5):341-50.
Hou YH, Srour EF, Ramsey H, Dahl R, Broxmeyer HE, Hromas R. Identification of a hu- man B-cell/myeloid common progenitor by the absence of CXCR4. Blood. 2005;105(9): 3488-92.
Escribano L, Ocqueteau M, Almeida J, Orfao A, San Miguel JF. Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis. Leuk Lymphoma. 1998;30(5-6):450-66.
Syrjälä M, Ruutu T, Jansson SE. A flow cytometric assay of CD34-positive cell populations in the bone marrow. Br J Haematol. 1994;88(4):679-84.
Edvarsson L, Dykes J, Olofsson T. Isolation and characterization of human myeloid proge- nitor populations--TpoR as discriminator between common myeloid and megakaryocyte/ erythroid progenitors. Exp Hematol. 2006;34(5):599-609.
Orfao A, Ruiz-Arguelles A, Lacombe F, Ault K, Basso G, Danova M. Flow cytometry: its appli- cations in hematology. Haematologica. 1995;80(1):69-81.
Ratajczak MZ, Pletcher CH, Marlicz W, et al. CD34+, kit+, rhodamine123(low) phenotype identifies a marrow cell population highly enriched for human hematopoietic stem cells. Leukemia. 1998;12(6):942-50.
Pontvert-Delucq S, Breton-Gorius J, Schmitt C, Baillou C, Guichard J, Najman A, Lemoine FM. Characterization and functional analysis of adult human bone marrow cell subsets in relation to B-lymphoid development. Blood. 1993;82(2):417-29.
Terstappen LW, Huang S, Picker LJ. Flow cytometric assessment of human T-cell differentia- tion in thymus and bone marrow. Blood. 1992;79(3):666-77.
Bender JG, Unverzagt KL, Walker DE, et al. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multi- color flow cytometry. Blood. 1991;77(12):2591-6.
Spangrude GJ, Perry SS, Slayton WB. Early stages of hematopoietic differentiation. Ann N Y Acad Sci. 2003;996:186-94.
Loken MR, Shah VO, Dattilio KL, Civin CI. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood. 1987;70(5):1316-24.
Chabannon C, Wood P, Torok-Storb B. Expression of CD7 on normal human myeloid progeni- tors. J Immunol. 1992;149(6):2110-3.
Miller JS, Alley KA, McGlave P. Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of CD34+7+ NK progenitor. Blood. 1994;83(9):2594-601.
Inaba T, Shimazaki C, Hirata T, et al. Phenotypic differences of CD34-positive stem cells harvested from peripheral blood and bone marrow obtained before and after peripheral blood stem cell collection. Bone Marrow Transplant. 1994;13(5):527-32.
Smeland EB, Funderud S, Kvalheim G, et al. Isolation and characterization of human he- matopoietic progenitor cells: an effective method for positive selection of CD34+ cells. Leukemia. 1992;6(8):845-52.
Rutella S, Bonanno C, Marone M, et al. Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differen- tiation after in vitro exposure to IL-15. J Immunol. 2003;171(6):2977-88.
Perez SA, Sotiropoulou PA, Gkika DG, et al. A novel myeloid-like NK cell progenitor in human umbilical cord blood. Blood. 2003;101(9):3444-50.
Sconocchia G, Fujiwara H, Rezvani K, et al. G-CSF mobilized CD34+ cells cultured in in- terleukin-2 and stem cell factor generate a phenotypically novel monocyte. J Leukoc Biol. 2004;76(6):1214-9.
Mouthon MA, Freund M, Titeux M, et al. Growth and differentiation of the human megaka- ryoblastic cell line (ELF-153): a model for early stages of megakaryocytopoiesis. Blood. 1994;84(4):1085-97.
Sperling C, Schwartz S, Büchner T, Thiel E, Ludwig WD. Expression of the stem cell factor receptor C-KIT (CD117) in acute leukemias. Haematologica. 1997;82(5):617-21.
Ashman LK, Cambareri AC, To LB, Levinsky RJ, Juttner CA. Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood. 1991;78(1):30-7.
Ishikawa F, Livingston AG, Minamiquchi H, Wingard JR, Ogawa M. Human cord blood long- term engrafting cells are CD34+ CD38-. Leukemia. 2003;17(5):960-4.
Tian H, Huang S, Gong F, Tian L, Chen Z. Karyotyping, immunophenotyping, and apoptosis analyses in human hematopoietic precursor cells derived from umbilical cord blood follo- wing long-term ex vivo expansion. Cancer Genet Cytogenet. 2005;157(1):33-6.
Shim MH, Hoover A, Blake N, Drachman JG, Reems JA. Gene expression profile of primary human CD34+CD38lo cells differentiating along the megakaryocyte lineage. Exp Hematol. 2004;32(7):638-48.
Massa M, Rosti V, Ferrario M, et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood. 2005;105(1): 199-206.
